CEN/TC 140
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 62543 | EN ISO 22870:2016 | Point-of-care testing (POCT) - Requirements for quality and competence (ISO 22870:2016) | Atcelts |
| 37591 | LVS EN ISO 18113-3:2012 | In vitro diagnostic medical devices - Information supplied by the manufacturer (labelling) - Part 3: In vitro diagnostic instruments for professional use (ISO 18113-3:2009) | Atcelts |
| 37208 | EN ISO 16256:2012 | Clinical laboratory testing and in vitro diagnostic test systems - Reference method for testing the in vitro activity of antimicrobial agents against yeast of fungi involved in infectious diseases (ISO 16256:2012) | Atcelts |
| 29669 | EN ISO 15189:2012 | Medical laboratories - Requirements for quality and competence (ISO/DIS 15189:2011) | Atcelts |
| 5068 | EN 376:1992 | In vitro diagnostic systems - Requirements for labelling in vitro diagnostic reagents for self-testing | Atcelts |
| 5104 | EN 13640:2002 | Stability testing of in vitro diagnostic reagents | Atcelts |
| 41042 | CEN/TS 16827-1:2015 | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for FFPE tissue - Part 1: Isolated RNA | Atcelts |
| 41044 | LVS CEN/TS 16827-3:2015 | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for FFPE tissue - Part 3: Isolated DNA | Atcelts |
| 33817 | EN ISO 15197:2013 | In vitro diagnostic test systems - Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus (ISO 15197:2013) | Atcelts |
| 41044 | CEN/TS 16827-3:2015 | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for FFPE tissue - Part 3: Isolated DNA | Atcelts |
Displaying 101-110 of 272 results.